aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
2.990
-0.050 (-1.64%)
At close: Nov 20, 2024, 4:00 PM
2.931
-0.059 (-1.97%)
After-hours: Nov 20, 2024, 4:50 PM EST
aTyr Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.24 | 0.35 | 10.39 | - | 10.46 | 0.42 | Upgrade
|
| Revenue Growth (YoY) | -97.81% | -96.60% | - | - | 2377.49% | - | Upgrade
|
| Cost of Revenue | 54.9 | 42.29 | 42.81 | 23.26 | 17.29 | 14.05 | Upgrade
|
| Gross Profit | -54.66 | -41.94 | -32.42 | -23.26 | -6.84 | -13.63 | Upgrade
|
| Selling, General & Admin | 13.39 | 12.98 | 13.98 | 10.75 | 9.08 | 9.35 | Upgrade
|
| Operating Expenses | 13.39 | 12.98 | 13.98 | 10.75 | 9.08 | 9.35 | Upgrade
|
| Operating Income | -68.05 | -54.92 | -46.4 | -34.02 | -15.91 | -22.98 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.24 | 4.52 | 1.06 | 0.24 | -0.32 | -0.79 | Upgrade
|
| EBT Excluding Unusual Items | -63.82 | -50.4 | -45.34 | -33.78 | -16.23 | -23.76 | Upgrade
|
| Pretax Income | -63.82 | -50.4 | -45.34 | -33.78 | -16.23 | -23.76 | Upgrade
|
| Earnings From Continuing Operations | -63.82 | -50.4 | -45.34 | -33.78 | -16.23 | -23.76 | Upgrade
|
| Minority Interest in Earnings | -0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.16 | Upgrade
|
| Net Income | -63.82 | -50.39 | -45.34 | -33.77 | -16.22 | -23.6 | Upgrade
|
| Net Income to Common | -63.82 | -50.39 | -45.34 | -33.77 | -16.22 | -23.6 | Upgrade
|
| Shares Outstanding (Basic) | 68 | 54 | 28 | 19 | 9 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 68 | 54 | 28 | 19 | 9 | 3 | Upgrade
|
| Shares Change (YoY) | 48.50% | 88.63% | 48.94% | 108.30% | 172.98% | 56.66% | Upgrade
|
| EPS (Basic) | -0.93 | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 | Upgrade
|
| EPS (Diluted) | -0.93 | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 | Upgrade
|
| Free Cash Flow | -67.11 | -37.44 | -43.53 | -33.27 | -15.5 | -20.09 | Upgrade
|
| Free Cash Flow Per Share | -0.98 | -0.70 | -1.53 | -1.74 | -1.69 | -5.99 | Upgrade
|
| Gross Margin | - | - | - | - | -65.38% | - | Upgrade
|
| Operating Margin | -28958.72% | -15557.79% | -446.79% | - | -152.19% | -5445.02% | Upgrade
|
| Profit Margin | -27155.74% | -14274.50% | -436.53% | - | -155.18% | -5593.13% | Upgrade
|
| Free Cash Flow Margin | -28555.74% | -10605.10% | -419.09% | - | -148.28% | -4761.14% | Upgrade
|
| EBITDA | -67.35 | -54.33 | -46.17 | -33.54 | -15.34 | -22.34 | Upgrade
|
| EBITDA Margin | - | - | - | - | -146.74% | - | Upgrade
|
| D&A For EBITDA | 0.71 | 0.59 | 0.23 | 0.48 | 0.57 | 0.64 | Upgrade
|
| EBIT | -68.05 | -54.92 | -46.4 | -34.02 | -15.91 | -22.98 | Upgrade
|
| EBIT Margin | - | - | - | - | -152.19% | - | Upgrade
|
| Revenue as Reported | 0.24 | 0.35 | 10.39 | - | 10.46 | 0.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.